Dr Paul W S Heng obtained his basic degree in pharmacy and doctorate degree in pharmaceutical technology from the National University of Singapore (NUS). He then joined the Department of Pharmacy, NUS and taught pharmaceutical technology for over three decades. He served as Head of Department, 2000-2004. He served as Head of Department for two terms, 2000-2004 and founded GEA-NUS Pharmaceutical Processing Research Laboratory in 1997, a research laboratory focused in process and product development related to pharmaceutical technology. Dr Heng has served several terms as Chairman of the Singapore’s Quality Control Advisory Committee which saw the acceptance of Singapore as a member of the PIC/S. His research interest is in pharmaceutical technology, especially research related to solid dosage forms, particulates, pellets and tablets. He has expertise with excipients, design of controlled release systems, inhalable systems, encapsulation technologies as well as various product quality testing such as flowability, dissolubility and stability. He has since retired as full-time NUS staff in June 2022 and is now an Honorary Fellow at NUS. He also has adjunct professorship appointments with Airlangga University and China Pharmaceutical University. In 2019, he co-founded a pharmaceutical technology centre, One North Pharmaceutical Research Institute at Nanjing, China for contract research. In academia, he has successfully supervised or co-supervised over 60 doctorate program students, several masters students, published over 330 international refereed research journal articles and has also written several book chapters and patents. He is the editor-in-chief of the Asian J Pharm Sci and is in the editorial boards of several other journals.